Published in Eur J Neurosci on January 01, 2008
Combined delivery of Nogo-A antibody, neurotrophin-3 and the NMDA-NR2d subunit establishes a functional 'detour' in the hemisected spinal cord. Eur J Neurosci (2011) 1.62
Nogo limits neural plasticity and recovery from injury. Curr Opin Neurobiol (2014) 1.42
Role of myelin-associated inhibitors in axonal repair after spinal cord injury. Exp Neurol (2011) 1.21
Serotonergic innervation of the caudal spinal stump in rats after complete spinal transection: effect of olfactory ensheathing glia. J Comp Neurol (2009) 0.95
Small-molecule-induced Rho-inhibition: NSAIDs after spinal cord injury. Cell Tissue Res (2012) 0.93
Plasticity of intact rubral projections mediates spontaneous recovery of function after corticospinal tract injury. J Neurosci (2015) 0.87
Axon plasticity in the mammalian central nervous system after injury. Trends Neurosci (2014) 0.83
Treatment of rat spinal cord injury with the neurotrophic factor albumin-oleic acid: translational application for paralysis, spasticity and pain. PLoS One (2011) 0.82
Noradrenergic innervation of the rat spinal cord caudal to a complete spinal cord transection: effects of olfactory ensheathing glia. Exp Neurol (2009) 0.81
Refining the Role of 5-HT in Postnatal Development of Brain Circuits. Front Cell Neurosci (2017) 0.80
Deletion of the Fractalkine Receptor, CX3CR1, Improves Endogenous Repair, Axon Sprouting, and Synaptogenesis after Spinal Cord Injury in Mice. J Neurosci (2017) 0.75
EphrinA5 Signaling Is Required for the Distinctive Targeting of Raphe Serotonin Neurons in the Forebrain. eNeuro (2017) 0.75
Nogo-A expression dynamically varies after spinal cord injury. Neural Regen Res (2015) 0.75
The injured spinal cord spontaneously forms a new intraspinal circuit in adult rats. Nat Neurosci (2004) 5.36
In vivo imaging of axonal degeneration and regeneration in the injured spinal cord. Nat Med (2005) 3.88
Nogo-A-specific antibody treatment enhances sprouting and functional recovery after cervical lesion in adult primates. Nat Med (2006) 3.23
Systemic deletion of the myelin-associated outgrowth inhibitor Nogo-A improves regenerative and plastic responses after spinal cord injury. Neuron (2003) 2.32
Combining Schwann cell bridges and olfactory-ensheathing glia grafts with chondroitinase promotes locomotor recovery after complete transection of the spinal cord. J Neurosci (2005) 2.30
Can experiments in nonhuman primates expedite the translation of treatments for spinal cord injury in humans? Nat Med (2007) 2.29
Patterns of Nogo mRNA and protein expression in the developing and adult rat and after CNS lesions. J Neurosci (2002) 2.27
Improving outcome after stroke: overcoming the translational roadblock. Cerebrovasc Dis (2008) 2.26
Nogo-A antibody improves regeneration and locomotion of spinal cord-injured rats. Ann Neurol (2005) 2.22
Nogo-A inhibits neurite outgrowth and cell spreading with three discrete regions. J Neurosci (2003) 2.03
Nogo and its paRTNers. Trends Cell Biol (2003) 1.90
Nogo-A-deficient mice reveal strain-dependent differences in axonal regeneration. J Neurosci (2006) 1.89
Constraint-induced movement therapy in the adult rat after unilateral corticospinal tract injury. J Neurosci (2008) 1.65
Combined delivery of Nogo-A antibody, neurotrophin-3 and the NMDA-NR2d subunit establishes a functional 'detour' in the hemisected spinal cord. Eur J Neurosci (2011) 1.62
Nogo-A, -B, and -C are found on the cell surface and interact together in many different cell types. J Biol Chem (2005) 1.61
Rewiring of the corticospinal tract in the adult rat after unilateral stroke and anti-Nogo-A therapy. Brain (2013) 1.59
Reorganization of descending motor tracts in the rat spinal cord. Eur J Neurosci (2002) 1.55
Deep brain stimulation of the midbrain locomotor region improves paretic hindlimb function after spinal cord injury in rats. Sci Transl Med (2013) 1.53
Inflammation, degeneration and regeneration in the injured spinal cord: insights from DNA microarrays. Trends Neurosci (2003) 1.52
Sprouting, regeneration and circuit formation in the injured spinal cord: factors and activity. Philos Trans R Soc Lond B Biol Sci (2006) 1.48
Delayed treatment with monoclonal antibody IN-1 1 week after stroke results in recovery of function and corticorubral plasticity in adult rats. J Cereb Blood Flow Metab (2005) 1.48
Functional recovery and neuroanatomical plasticity following middle cerebral artery occlusion and IN-1 antibody treatment in the adult rat. Ann Neurol (2002) 1.44
Anti-Nogo-A antibody infusion 24 hours after experimental stroke improved behavioral outcome and corticospinal plasticity in normotensive and spontaneously hypertensive rats. J Cereb Blood Flow Metab (2003) 1.42
Inhibition of Nogo: a key strategy to increase regeneration, plasticity and functional recovery of the lesioned central nervous system. Ann Med (2005) 1.42
A reticular rhapsody: phylogenic evolution and nomenclature of the RTN/Nogo gene family. FASEB J (2003) 1.42
Characterization of epidermal neural crest stem cell (EPI-NCSC) grafts in the lesioned spinal cord. Mol Cell Neurosci (2006) 1.38
Long-lasting sprouting and gene expression changes induced by the monoclonal antibody IN-1 in the adult spinal cord. J Neurosci (2002) 1.31
Targeting experimental autoimmune encephalomyelitis lesions to a predetermined axonal tract system allows for refined behavioral testing in an animal model of multiple sclerosis. Am J Pathol (2004) 1.31
Phosphorylated FTY720 promotes astrocyte migration through sphingosine-1-phosphate receptors. J Neurochem (2007) 1.30
Functional and anatomical reorganization of the sensory-motor cortex after incomplete spinal cord injury in adult rats. J Neurosci (2009) 1.28
Differential effects of anti-Nogo-A antibody treatment and treadmill training in rats with incomplete spinal cord injury. Brain (2009) 1.25
Remodeling of axonal connections contributes to recovery in an animal model of multiple sclerosis. J Exp Med (2004) 1.25
Genomic structure and functional characterisation of the promoters of human and mouse nogo/rtn4. J Mol Biol (2003) 1.23
Recovery and brain reorganization after stroke in adult and aged rats. Ann Neurol (2005) 1.23
Nogo-A stabilizes the architecture of hippocampal neurons. J Neurosci (2010) 1.22
The role of Nogo-A in axonal plasticity, regrowth and repair. Cell Tissue Res (2012) 1.22
Dendritic plasticity in the adult rat following middle cerebral artery occlusion and Nogo-a neutralization. Cereb Cortex (2005) 1.22
Rewiring of hindlimb corticospinal neurons after spinal cord injury. Nat Neurosci (2009) 1.20
Nogo-A and myelin-associated glycoprotein differently regulate oligodendrocyte maturation and myelin formation. J Neurosci (2008) 1.18
NogoA restricts synaptic plasticity in the adult hippocampus on a fast time scale. Proc Natl Acad Sci U S A (2011) 1.18
Chronic spinal hemisection in rats induces a progressive decline in transmission in uninjured fibers to motoneurons. Exp Neurol (2009) 1.18
Anti-Nogo on the go: from animal models to a clinical trial. Ann N Y Acad Sci (2010) 1.17
Anti-Nogo-A antibody treatment enhances sprouting of corticospinal axons rostral to a unilateral cervical spinal cord lesion in adult macaque monkey. J Comp Neurol (2007) 1.17
Synaptic destabilization by neuronal Nogo-A. Brain Cell Biol (2007) 1.17
Red nucleus projections to distinct motor neuron pools in the rat spinal cord. J Comp Neurol (2002) 1.16
Neuronal Nogo-A regulates neurite fasciculation, branching and extension in the developing nervous system. Development (2010) 1.13
Combination treatment with anti-Nogo-A and chondroitinase ABC is more effective than single treatments at enhancing functional recovery after spinal cord injury. Eur J Neurosci (2013) 1.12
Long-distance axonal regeneration induced by CNTF gene transfer is impaired by axonal misguidance in the injured adult optic nerve. Neurobiol Dis (2012) 1.10
Pincher-generated Nogo-A endosomes mediate growth cone collapse and retrograde signaling. J Cell Biol (2010) 1.09
The neurite outgrowth inhibitor Nogo-A promotes denervation in an amyotrophic lateral sclerosis model. EMBO Rep (2006) 1.09
Chondroitinase ABC combined with neurotrophin NT-3 secretion and NR2D expression promotes axonal plasticity and functional recovery in rats with lateral hemisection of the spinal cord. J Neurosci (2011) 1.09
Defeating inhibition of regeneration by scar and myelin components. Handb Clin Neurol (2012) 1.07
Role of Nogo-A in neuronal survival in the reperfused ischemic brain. J Cereb Blood Flow Metab (2010) 1.06
Neuronal Nogo-A modulates growth cone motility via Rho-GTP/LIMK1/cofilin in the unlesioned adult nervous system. J Biol Chem (2009) 1.06
Functional reorganization in rat somatosensory cortex assessed by fMRI: elastic image registration based on structural landmarks in fMRI images and application to spinal cord injured rats. Neuroimage (2008) 1.05
Delayed anti-nogo-a therapy improves function after chronic stroke in adult rats. Stroke (2010) 1.04
Intrathecally infused antibodies against Nogo-A penetrate the CNS and downregulate the endogenous neurite growth inhibitor Nogo-A. Mol Cell Neurosci (2006) 1.03
The rocky road to translation in spinal cord repair. Ann Neurol (2012) 1.02
Nogo-A is a negative regulator of CNS angiogenesis. Proc Natl Acad Sci U S A (2013) 1.02
Anti-Nogo-A antibody treatment promotes recovery of manual dexterity after unilateral cervical lesion in adult primates--re-examination and extension of behavioral data. Eur J Neurosci (2009) 1.02
Intrathecal treatment with anti-Nogo-A antibody improves functional recovery in adult rats after stroke. Exp Brain Res (2007) 1.01
Nogo-A represses anatomical and synaptic plasticity in the central nervous system. Physiology (Bethesda) (2013) 1.00
Regulation of Nogo and Nogo receptor during the development of the entorhino-hippocampal pathway and after adult hippocampal lesions. Mol Cell Neurosci (2004) 0.99
Nogo-A expression after focal ischemic stroke in the adult rat. Stroke (2008) 0.99
Detrimental role for human high temperature requirement serine protease A1 (HTRA1) in the pathogenesis of intervertebral disc (IVD) degeneration. J Biol Chem (2012) 0.99
Cell-autonomous mechanisms and myelin-associated factors contribute to the development of Purkinje axon intracortical plexus in the rat cerebellum. J Neurosci (2003) 0.98
Sequential loss of myelin proteins during Wallerian degeneration in the rat spinal cord. Glia (2003) 0.96
Neutralization of inhibitory molecule NG2 improves synaptic transmission, retrograde transport, and locomotor function after spinal cord injury in adult rats. J Neurosci (2013) 0.96
Nogo-a regulates neural precursor migration in the embryonic mouse cortex. Cereb Cortex (2010) 0.96
Distinct roles of Nogo-a and Nogo receptor 1 in the homeostatic regulation of adult neural stem cell function and neuroblast migration. J Neurosci (2012) 0.95
Profiling locomotor recovery: comprehensive quantification of impairments after CNS damage in rodents. Nat Methods (2010) 0.94
BMP2 and FGF2 cooperate to induce neural-crest-like fates from fetal and adult CNS stem cells. J Cell Sci (2005) 0.94
Do cancer cells die because of Nogo-B? Oncogene (2003) 0.94
Heterogeneous spine loss in layer 5 cortical neurons after spinal cord injury. Cereb Cortex (2011) 0.94
Functional reorganization of the motor cortex in adult rats after cortical lesion and treatment with monoclonal antibody IN-1. J Neurosci (2003) 0.93
Neuronal Nogo-A negatively regulates dendritic morphology and synaptic transmission in the cerebellum. Proc Natl Acad Sci U S A (2012) 0.93
Sacral dome resection and single-stage posterior reduction in the treatment of high-grade high dysplastic spondylolisthesis in adolescents and young adults. Eur Spine J (2011) 0.92
Cognitive recovery in the aged rat after stroke and anti-Nogo-A immunotherapy. Behav Brain Res (2009) 0.92
Neutralization of the membrane protein Nogo-A enhances growth and reactive sprouting in established organotypic hippocampal slice cultures. Eur J Neurosci (2008) 0.92
Anti-Nogo-A antibody treatment does not prevent cell body shrinkage in the motor cortex in adult monkeys subjected to unilateral cervical cord lesion. BMC Neurosci (2008) 0.92
Constitutive genetic deletion of the growth regulator Nogo-A induces schizophrenia-related endophenotypes. J Neurosci (2010) 0.92
Nogo receptor antagonizes p75NTR-dependent motor neuron death. Proc Natl Acad Sci U S A (2008) 0.91
Cognitive outcome following brain injury and treatment with an inhibitor of Nogo-A in association with an attenuated downregulation of hippocampal growth-associated protein-43 expression. J Neurosurg (2007) 0.91
Nogo and Nogo receptor: relevance to schizophrenia? Neurobiol Dis (2013) 0.90